|
CCNI expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.249500E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.935700E-03 |
| Normal-vs-Stage2 |
4.558100E-02 |
| Normal-vs-Stage3 |
1.449710E-04 |
| Normal-vs-Stage4 |
7.995700E-03 |
| Stage1-vs-Stage2 |
6.624200E-01 |
| Stage1-vs-Stage3 |
2.067600E-01 |
| Stage1-vs-Stage4 |
8.556600E-01 |
| Stage2-vs-Stage3 |
2.051800E-01 |
| Stage2-vs-Stage4 |
6.224600E-01 |
| Stage3-vs-Stage4 |
4.622400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.352900E-04 |
| Normal-vs-AfricanAmerican |
7.491200E-01 |
| Normal-vs-Asian |
5.264300E-03 |
| Caucasian-vs-AfricanAmerican |
2.439700E-02 |
| Caucasian-vs-Asian |
9.539200E-01 |
| AfricanAmerican-vs-Asian |
5.396300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.225600E-04 |
| Normal-vs-Female |
1.659320E-03 |
| Male-vs-Female |
3.212200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.544000E-03 |
| Normal-vs-Age(41-60Yrs) |
4.826000E-04 |
| Normal-vs-Age(61-80Yrs) |
2.717100E-03 |
| Normal-vs-Age(81-100Yrs) |
4.709800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.687400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.038800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.125200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.303200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.869200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.890000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.576800E-01 |
| Classical-VS-Follicular |
4.738000E-01 |
| Classical-VS-Other |
5.462400E-01 |
| Classical-VS-Normal |
3.682900E-03 |
| Tall-VS-Follicular |
5.160800E-01 |
| Tall-VS-Other |
9.548200E-01 |
| Tall-VS-Normal |
1.015200E-03 |
| Follicular-VS-Other |
7.489200E-01 |
| Follicular-VS-Normal |
5.040700E-03 |
| Other-VS-Normal |
9.142500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.003100E-04 |
| Normal-vs-N1 |
1.611450E-04 |
| N0-vs-N1 |
1.310600E-01 |
|
|
